Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer. - William WN Jr; Kies MS; Fossella FV; Liu DD; Gladish G; Tse WH; Lee JJ; Hong WK; Lippman SM; Kim ES; William, William N Jr; Kies, Merrill S; et al. (Cancer (0008543X), 2010)